Receptor mediation in cannabinoid stimulated arachidonic acid mobilization and anandamide synthesis

Life Sciences

Volumn 60, Issue 18, 1997, Pages 1563-1573

  Hunter, Sheila A ^a   Burstein, Sumner H ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

anandamide; antisense oligonucleotides; arachidonic acid; cannabinoid

Indexed keywords

ANANDAMIDE; ANTISENSE OLIGONUCLEOTIDE; ARACHIDONIC ACID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID CB1 RECEPTOR ANTAGONIST; CANNABINOID RECEPTOR; DRONABINOL; OLIGONUCLEOTIDE; RADIOISOTOPE; RIMONABANT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTICLE; BIOSYNTHESIS; CELL LINE; CONTROLLED STUDY; DRUG ANTAGONISM; HUMAN; HUMAN CELL; ICOSANOID METABOLISM; IMMUNOBLOTTING; LUNG FIBROBLAST; MACROPHAGE; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; ARACHIDONIC ACID; ARACHIDONIC ACIDS; BLOTTING, WESTERN; CELL LINE; HUMANS; MICE; OLIGONUCLEOTIDES, ANTISENSE; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; TETRAHYDROCANNABINOL; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0030940056     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(97)00122-7     Document Type: Article

References (21)

1. S. BURSTEIN. Marijuana/Cannabinoids (Murphy, L., and Bartke,A., eds.) Chapter 3, pp. 73-91, CRC Press, Boca Raton (1992)..
2. S. BURSTEIN, J.K. YOUNG, and G.E. WRIGHT. Biochem. Pharmacol. 50 1735-1742 (1995).
3. A.C. HOWLETT. Cannabinoid Receptors (Pertwee, R. ed) Chapter 6, pp. 168-197, Academic Press, London (1995).
4. S. BURSTEIN, J. BUDROW, M. DEBATIS, S.A. HUNTER, and A. SUBRAMANIAN. Biochem. Pharmacol., 48 1253-1264 (1994).
5. M. WARTMANN, D. CAMPBELL, A. SUBRAMANIAN, S.H. BURSTEIN, and R.J. DAVIS. FEBS Letts., 359 133-136 (1995).
6. S.A. EDSALL, R.J. KNAPP, T.W. VANDERAH, W.R. ROESKE, P. CONSROE and H.I. YAMAMURA. NeuroReport, 7 593-596 (1996).
7. L.A. MATSUDA, S.J. LOLAIT, M.J. BROWNSTEIN., A.C. YOUNG, and T.I. BONNER. Nature, 346 561-564 (1990).
8. S. MUNRO, K.L. THOMAS, and M. ABU-SHAAR. Nature, 365 61-65 (1993).
9. C. SONG, and A.C. HOWLETT. Life Sci., 56 1983-1989 (1995).
10. M. RINALDI-CARMONA, F. BARTH, M. HEAULME, D. SHIRE, B. CALANDRA, G. CONGY, S. MARTINEZ, J. MARUANI, N. GERVAIS, D. CAPUT, P. FERRARA, P. SOUBRIE, J.C. BRELIERE, and G. LE FUR. FEBS Letts. 350 240-244 (1994).
11. S. BURSTEIN, and S.A. HUNTER. J. Clin. Pharmacol., 21 240S-248S (1981).
12. S. BURSTEIN, S.A. HUNTER, C. SEDOR, and S. SHULMAN. Biochem. Pharmacol., 31 2361-2365 (1982).
13. S. BURSTEIN., S.A. HUNTER, and K. OZMAN. Mol. Pharmacol., 23 121-126 (1983).
14. S.A. HUNTER, S. BURSTEIN., and C. SEDOR. Biochim. Biophys. Acta, 793 202-212 (1984).
15. S. BURSTEIN, S.A. HUNTER, and L. RENZULLI. J. Pharmacol. Exper. Therap., 235 87-91 (1985)
16. S. BURSTEIN, S.A. HUNTER, V. LATHAM, and L. RENZULLI. Biochem. Pharmacol., 35 2553-2558 (1986).
17. R.G. PERTWEE. in Cannabinoid Receptors (Pertwee, R. ed) Chapter 1, pp. 1-34, Academic Press, London (1995).
18. C.C. FELDER, J.S. VELUZ, H.L. WILLIAMS, E.M. BRILEY and L.A. MATSUDA. Mol. Pharmacol. 42 838-845 (1992).
19. A.C. SHIVACHAR, B.R. MARTIN, and E.F. ELLIS. Biochem. Pharmacol. 51 669-676 (1996).
20. S.H. BURSTEIN, and S.A. HUNTER. Biochem. Pharmacol. 49 855-858 (1995).
21. V. DiMARZO and A. FONTANA. Prost. Leuk. Essential Fatty Acids 53 1-11 (1995).